Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 391 record(s)

Req # A-2021-00033

Records about the 2021 Snow Crab Fishery Area 12, and the incident that occured on April 3, 2021, where TYHAWK Capsized.

Organization: Transportation Safety Board of Canada

0 page(s)
July 2021

Req # A-2021-00037

M06L0063- Copy of the engineering report on the Sea Urchin 2006, report LP042/2006 cited as more detailed related to the Accidental Release of the Life Boat.

Organization: Transportation Safety Board of Canada

16 page(s)
July 2021

Req # A-2021-00039

All communications from Mr. Bill Gates, Ms. Gates French, The Bill and Melinda Gates Foundation, Cascade Investment, L.L.C, and their representatives/employees regarding their lobbying in favor of amending the CN Commercialization Act, SC 1995, through the Transportation Modernization Act (Bill C-49, assented to 2018-05-23) between the dates of January 2016 to January 2019.

Organization: Transportation Safety Board of Canada

0 page(s)
July 2021

Req # A-2021-09955

Copy of the French version of the February 9, 2021 communication plan titled "Modern and Proactive Communications Strategy".

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
June 2021

Req # A-2021-11663

A copy of the release package that was disclosed in response to access to information request file number A-2021-007891.

Organization: Patented Medicine Prices Review Board Canada

95 page(s)
June 2021

Req # A-2021-11666

A copy of the PMPRB's 6-page Communication Plan, "Modern and Proactive Communications Strategy", dated February 9, 2021 as previously disclosed in a release package in response to an access to information request.

Organization: Patented Medicine Prices Review Board Canada

6 page(s)
June 2021

Req # A-2021-11668

Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.

Organization: Patented Medicine Prices Review Board Canada

3 page(s)
June 2021

Req # A-2021-00010

Records if TSB routinely, as a matter of policy, or in single instances, has ever informed its incident investigators about their right or duty to disclose potentially criminal wrongdoing to independent public police forces wrongdoing to independent public police forces

Organization: Transportation Safety Board of Canada

12 page(s)
June 2021

Nothing to report this month

Organization: Transportation Safety Board of Canada

June 2021

Req # A-2021-07238

Copies of all information, data, document, or correspondence concerning the PMPRB's classification of the following drug products: NOVORAPID and FIASP, each a product of NOVO NORDISK CANADA INC, a corporation located at 101-2476 Argentia Road, Mississauga, Ontario, Canada L5N 6M1, including but not limited to classifications based on drug product line extensions, similar chemical entities, comparable dosages, or a reasonable relationship between the two drugs, as well as any other analysis, comments, or information related to the classification of these two drugs.

Organization: Patented Medicine Prices Review Board Canada

12 page(s)
May 2021
Date modified: